Answers are grounded in this paper and cite their sources.
Non-inferiority tests for comparing two binomial proportions are frequently used in clinical trials to prove that a new drug with few side effects or low cost is not significantly inferior in efficacy to the standard drug. This article gives a brief summary of the statistical framework for assessing non-inferiority and presents some of the more popular non-inferiority tests. The main conclusion is that the Farrington-Manning test with continuity correction is the recommended non-inferiority test for comparing two binomial proportions.
No takes yet. Share an insight, caveat, or question.
David Sotres‐Ramos (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: